Latest filing published 20 Sept 2026 for Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp., €37k.
No signal scores available.
Kim David Morris Oishi appears in our data through filings on Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. shares, published by SEDI. The record holds 6 filings, for trades running from 27 January 2026 to 16 September 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 20 September 2026: an option exercise of €37k, in Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations